Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · February 28, 2013

CXL is a Safe, Effective Stabilizing Strategy for Progressive Mild-to-Moderate Keratoconus

Canadian Journal of Ophthalmology

 

Additional Info

Canadian Journal of Ophthalmology
Corneal Collagen Cross-Linking Using Riboflavin and Ultraviolet A for the Treatment of Mild to Moderate Keratoconus: 2-Year Follow-Up
Can J Ophthalmol 2013 Feb 01;48(1)63-68, ME Legare, A Iovieno, SN Yeung, et al

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading